share_log

国邦医药(605507.SH):浙民投恒华、丝路基金拟减持不超过3%股份

Guobang Pharmaceutical (605507.SH): Zhejiang Minjin Investment Henghua and Silk Road Fund plan to reduce their holdings by no more than 3%

Gelonghui Finance ·  Apr 18 04:19

Gelonghui, April 18 | Guobang Pharmaceutical (605507.SH) announced that due to their own capital requirements, shareholders Zhejiang Minjin Henghua and Silk Road Fund plan to reduce their holdings of the company's total shares by no more than 16,764,705 shares through centralized bidding and bulk transactions, with a reduction ratio of no more than 3% of the company's total share capital.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment